<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-17T04:14:21Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/8700" metadataPrefix="edm">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/8700</identifier><datestamp>2024-02-20T01:05:23Z</datestamp><setSpec>com_10259_5645</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4734</setSpec><setSpec>com_10259_7906</setSpec><setSpec>col_10259_5646</setSpec><setSpec>col_10259_4735</setSpec><setSpec>col_10259_8017</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO rdf:about="http://hdl.handle.net/10259/8700">
<dc:creator>Sáiz Vázquez, Olalla</dc:creator>
<dc:creator>Puente Martínez, Alicia</dc:creator>
<dc:creator>Ubillos Landa, Silvia</dc:creator>
<dc:creator>Pacheco Bonrostro, Joaquín</dc:creator>
<dc:creator>Santabárbara, Javier</dc:creator>
<dc:date>2020-06</dc:date>
<dc:description>Alzheimer’s disease (AD) is the most common subtype of dementia. In the last ten years, the relationship between cholesterol and AD has been investigated. Evidence suggests that cholesterol is associated with AD and represents promising targets for intervention. However, the causality of these associations is unclear. Therefore, we sought to conduct a meta-meta-analysis to determine the effect of cholesterol on the development AD. Then, we assessed the effect of serum levels of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC) and triglycerides (TG), on AD risk.</dc:description>
<dc:identifier>http://hdl.handle.net/10259/8700</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>MDPI</dc:publisher>
<dc:title>Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation rdf:about="http://hdl.handle.net/10259/8700#aggregation">
<edm:aggregatedCHO rdf:resource="http://hdl.handle.net/10259/8700"/>
<edm:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</edm:dataProvider>
<edm:isShownAt rdf:resource="http://hdl.handle.net/10259/8700"/>
<edm:isShownBy rdf:resource="https://riubu.ubu.es/bitstream/10259/8700/1/Saiz-bs_2020.pdf"/>
<edm:object rdf:resource="https://riubu.ubu.es/bitstream/10259/8700/4/Saiz-bs_2020.pdf.jpg"/>
<edm:provider>Hispana</edm:provider>
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</ore:Aggregation>
<edm:WebResource rdf:about="https://riubu.ubu.es/bitstream/10259/8700/1/Saiz-bs_2020.pdf">
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</edm:WebResource>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>